Estados Unidos - inglés - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium sulfate (unii: 1k573lc5tv) (sulfate ion - unii:7is9n8kpmg), magnesium sulfate anhydrous (unii: ml30mj2u7i) (magnesium cation - unii:t6v3lhy838) - sodium sulfate, potassium sulfate and magnesium sulfate oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adults. - gastrointestinal obstruction - bowel perforation - gastric retention - ileus - toxic colitis or toxic megacolon - known allergies to components of the kit [see description (11)] teratogenic effects: pregnancy category c. animal reproduction studies have not been conducted with sodium sulfate, potassium sulfate and magnesium sulfate oral solution. it is also not known whether sodium sulfate, potassium sulfate and magnesium sulfate oral solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. sodium sulfate, potassium sulfate and magnesium sulfate oral solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when sodium sulfate, potassium sulfate and magnesium sulfate oral solution is administered to a nursing woman. safety and effectiveness in pediatric patients have not been established. of the 375 patients who received sodium sulfate, potassium sulfate and magnesium sulfate oral solution in clinical trials, 94 (25%) were 65 years of age or older, and 25 (7%) were 75 years of age or older. no overall differences in safety or effectiveness of sodium sulfate, potassium sulfate and magnesium sulfate oral solution administered as a split-dose (2-day) regimen were observed between geriatric patients and younger patients. geriatric patients reported more vomiting when sodium sulfate, potassium sulfate and magnesium sulfate oral solution was given as a one-day preparation.

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - sodium chloride - solvent for parenteral use - 0.9 %v/w - sodium chloride

Malta - inglés - Medicines Authority

baxter healthcare limited - sodium chloride - solution for infusion - sodium chloride 0.9 percent weight/volume - blood substitutes and perfusion solutions

Australia - inglés - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited t/a radpharm scientific - sodium oxidronate, quantity: 3.15 mg - injection, powder for - excipient ingredients: sodium chloride; stannous chloride dihydrate; dilute hydrochloric acid; gentisic acid; sodium hydroxide - technetium [99m tc] sodium oxidronate is a diagnostic skeletal imaging agent to demonstrate areas of altered osteogenesis in adult patients.

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

syri limited, t/a thame laboratories - sodium chloride - oral solution - 5 millimole(s)/millilitre - sodium chloride

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - sodium chloride

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - sodium chloride

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - sodium chloride

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

syri pharma limited t/a thame laboratories - sodium chloride - oral solution - 5 millimole(s)/millilitre - sodium chloride

Estados Unidos - inglés - NLM (National Library of Medicine)

novel laboratories, inc. - sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium sulfate (unii: 1k573lc5tv) (sulfate ion - unii:7is9n8kpmg), magnesium sulfate anhydrous (unii: ml30mj2u7i) (magnesium cation - unii:t6v3lhy838) - sodium sulfate, potassium sulfate and magnesium sulfate oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adults. - gastrointestinal obstruction - bowel perforation - gastric retention - ileus - toxic colitis or toxic megacolon - known allergies to components of the kit [see description (11)] teratogenic effects: pregnancy category c. animal reproduction studies have not been conducted with sodium sulfate, potassium sulfate and magnesium sulfate oral solution. it is also not known whether sodium sulfate, potassium sulfate and magnesium sulfate oral solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. sodium sulfate, potassium sulfate and magnesium sulfate oral solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when sodium sulfate, potassium sulfate and magnesium